Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Effectiveness of the Miranda Acquiescence Questionnaire for Investigating Impaired Miranda Reasoning.

Rogers R, Otal T, Drogin EY, Dean BM.

J Am Acad Psychiatry Law. 2020 Feb 12. pii: JAAPL.003912-20. doi: 10.29158/JAAPL.003912-20. [Epub ahead of print]

PMID:
32051204
2.

Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.

Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EA, Bottazzo GF.

Diabetologia. 1992 Apr;35(4):385-8.

PMID:
1516768
3.

Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus.

Bottazzo GF, Genovese S, Bosi E, Dean BM, Christie MR, Bonifacio E.

Ann Med. 1991 Oct;23(4):453-61. Review.

PMID:
1930942
4.

Does exposure to rubella virus generate endocrine autoimmunity?

Bodansky HJ, Dean BM, Grant PJ, McNally J, Schweiger MS, Hambling MH, Bottazzo GF, Wales JK.

Diabet Med. 1990 Aug;7(7):611-4.

PMID:
2146069
5.

Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.

Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF.

Lancet. 1990 Jan 20;335(8682):147-9.

PMID:
1967440
6.

On the pathogenesis of type 1 (insulin-dependent) diabetes mellitus: facts, areas still under development and new perspectives.

Bottazzo GF, Bonifacio E, Wagner R, al-Sakkaf L, Dean BM, Mirakian R.

Klin Wochenschr. 1990;68 Suppl 21:26-37. Review.

PMID:
2198388
7.

Comparison of insulin autoantibodies in diabetes-related and healthy populations by precise displacement ELISA.

Dean BM, McNally JM, Bonifacio E, Jennings AM, Dunger DB, Gale EA, Bottazzo GF.

Diabetes. 1989 Oct;38(10):1275-81.

PMID:
2676657
8.

Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.

Jennings AM, Spencer KM, Dean BM, Wilson RM, Bottazzo GF, Ward JD.

Diabet Med. 1989 Jul;6(5):434-9.

PMID:
2527682
9.

Predicting insulin-dependent diabetes.

Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EA.

Lancet. 1988 Apr 16;1(8590):845-50.

PMID:
2895363
10.

Interferon-gamma induces class II MHC antigens on RINm5F cells.

Varey AM, Lydyard PM, Dean BM, Van der Meide PH, Baird JD, Cooke A.

Diabetes. 1988 Feb;37(2):209-12.

PMID:
2839386
11.

Insulin responses and lymphocyte subclasses in children with newly diagnosed insulin-dependent diabetes.

Scheinin T, Mäenpää J, Koskimies S, Dean BM, Bottazzo GF, Kontiainen S.

Clin Exp Immunol. 1988 Jan;71(1):91-5.

12.

Insulin autoantibodies, islet cell surface antibodies and the development of spontaneous diabetes in the BB/Edinburgh rat.

Dean BM, Bone AJ, Varey AM, Walker R, Baird JD, Cooke A.

Clin Exp Immunol. 1987 Aug;69(2):308-13.

13.

Pre-diabetes in the spontaneously diabetic BB/E rat: pancreatic infiltration and islet cell proliferation.

Bone AJ, Walker R, Dean BM, Baird JD, Cooke A.

Acta Endocrinol (Copenh). 1987 Aug;115(4):447-54.

PMID:
3307260
14.

Immunological responses of the BB rat colony in Edinburgh.

Varey AM, Dean BM, Walker R, Bone AJ, Baird JD, Cooke A.

Immunology. 1987 Jan;60(1):131-4.

15.

Islet-cell antibodies and insulin autoantibodies in association with common viral infections.

Bodansky HJ, Grant PJ, Dean BM, McNally J, Bottazzo GF, Hambling MH, Wales JK.

Lancet. 1986 Dec 13;2(8520):1351-3.

PMID:
2878223
16.

Induction of class II MHC antigens in vitro on pancreatic B cells isolated from BB/E rats.

Walker R, Cooke A, Bone AJ, Dean BM, van der Meide P, Baird JD.

Diabetologia. 1986 Oct;29(10):749-51.

PMID:
3542673
17.

Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes.

Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EA, Bottazzo GF.

Diabetologia. 1986 May;29(5):339-42.

PMID:
3522332
18.

In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR.

N Engl J Med. 1985 Aug 8;313(6):353-60.

PMID:
3159965
20.

Predicting and preventing insulin-dependent diabetes mellitus.

Dean BM, Walker R, Bone AJ, Cooke A, Baird JD.

Lancet. 1985 May 4;1(8436):1043. No abstract available.

PMID:
2859487
21.

[Hypotheses on the etiology of insulin-dependent diabetes: published and recent ideas].

Bottazzo GF, al-Sakkaf L, Dean BM, Schwarz G, Pujol-Borrell R.

Journ Annu Diabetol Hotel Dieu. 1985:135-47. Review. French. No abstract available.

PMID:
2577958
22.

Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes.

Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF.

Lancet. 1984 Apr 7;1(8380):764-6.

PMID:
6143085
23.

Which virus causes the initial islet lesion in type 1 diabetes?

Bodansky HJ, Littlewood JM, Bottazzo GF, Dean BM, Hambling MH.

Lancet. 1984 Feb 18;1(8373):401-2. No abstract available.

PMID:
6141467
24.
25.

Islet-cell antibody determination: the essential message.

Dean BM, Pujol-Borrell R, Doniach D, Bottazzo GF.

Lancet. 1983 Mar 19;1(8325):654. No abstract available.

PMID:
6131335
26.

Determination of islet cell antibodies by immunofluorescence.

Dean BM, Pujol-Borrell R, Botazzo GF.

Lancet. 1982 Dec 11;2(8311):1343-4. No abstract available.

PMID:
6128629
27.

Genetic and immunologic factors in microvascular disease in type I insulin-dependent diabetes.

Bodansky HJ, Wolf E, Cudworth AG, Dean BM, Nineham LJ, Bottazzo GF, Matthews JA, Kurtz AB, Kohner EM.

Diabetes. 1982 Jan;31(1):70-4.

PMID:
6759215
28.

Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.

Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG.

Lancet. 1981 Dec 19-26;2(8260-61):1363-5.

PMID:
6118756
29.

[Recent progess in the autoimmune aspects of diabetes].

Bottazzo GF, Doniach D, Dean BM, Cudworth AG.

Journ Annu Diabetol Hotel Dieu. 1981:101-18. Review. French. No abstract available.

PMID:
6454021
30.

Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage.

Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D.

Lancet. 1980 Mar 29;1(8170):668-72.

PMID:
6103089
31.

Evidence that type I diabetes and thyrogastric autoimmunity have different genetic determinants.

Gorsuch AN, Dean BM, Bottazzo GF, Lister J, Cudworth AG.

Br Med J. 1980 Jan 19;280(6208):145-7.

32.

Adenine and adenosine metabolism in intact erythrocytes deficient in adenosine monophosphate-pyrophosphate phosphoribosyltransferase: a study of two families.

Dean BM, Perrett D, Simmonds HA, Sahota A, Van Acker KJ.

Clin Sci Mol Med. 1978 Oct;55(4):407-12. No abstract available.

PMID:
710055
33.

Changes in nucleotide concentrations in the erythrocytes of man, rabbit and rat during short-term storage.

Dean BM, Perrett D, Sensi M.

Biochem Biophys Res Commun. 1978 Jan 13;80(1):147-54. No abstract available.

PMID:
623649
34.
35.
36.

Thiopurinol and purine metabolism. Metabolic and radioisotope studies.

Simmonds HA, Cadenhead A, Cameron JS, Rising TJ, Grahame R, Dean BM.

Ann Rheum Dis. 1974 Nov;33(6):548-53. No abstract available.

37.

Proceedings: Metabolic studies of thiopurinol in man and pig.

Grahame R, Simmonds HA, Cadenhead A, Dean BM.

Ann Rheum Dis. 1974 Jul;33(4):409-10. No abstract available.

38.
39.

Metabolic studies of thiopurinol in man and the pig.

Grahame R, Simmonds HA, Cadenhead A, Dean BM.

Adv Exp Med Biol. 1974;41:597-605. No abstract available.

PMID:
4832586
40.

A comparative study of purine metabolism by human and pig erythrocytes in vitro.

Dean BM, Simmonds HA, Cadenhead A.

Biochem Pharmacol. 1973 Dec 15;22(24):3189-98. No abstract available.

PMID:
4358724
41.
42.

Studies on human erythrocyte IMP: pyrophosphate phosphoribosyltransferase.

Craft JA, Dean BM, Watts RW, Westwick WJ.

Eur J Biochem. 1970 Aug;15(2):367-73. No abstract available.

44.

Human erythrocyte AMP: Pyrophosphate phosphoribosyltransferase (EC 2.4.2.7).

Dean BM, Watts RW, Westwick WJ.

FEBS Lett. 1968 Aug;1(3):179-182. No abstract available.

46.

Primary hyperoxaluria. The demonstration of a metabolic abnormality in kidney tissue.

Dean BM, Griffin WJ, Watts RW.

Lancet. 1966 Feb 19;1(7434):406. No abstract available.

PMID:
4159786
47.

Quantitative aspects of ascorbic acid metabolism in patients with primary hyperoxaluria.

Atkins GL, Dean BM, Griffin WJ, Scowen EF, Watts RW.

Clin Sci. 1965 Oct;29(2):305-14. No abstract available.

PMID:
5840978
48.

QUANTITATIVE ASPECTS OF ASCORBIC ACID METABOLISM IN MAN.

ATKINS GL, DEAN BM, GRIFFIN WJ, WATTS RW.

J Biol Chem. 1964 Sep;239:2975-80. No abstract available.

49.

PRIMARY HYPEROXALURIA. THE RELATION BETWEEN ASCORBIC ACID AND THE INCREASED URINARY EXCRETION OF OXALATE.

ATKINS GL, DEAN BM, GRIFFIN WJ, SCOWEN EF, WATTS RW.

Lancet. 1963 Nov 23;2(7317):1096-7. No abstract available.

PMID:
14063425

Supplemental Content

Support Center